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ORIGINAL RESEARCH
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SUMMARY
Interleukin (IL27) suppresses atrophy and metaplasia during chronic autoimmune gastritis. Mice lacking IL27 rapidly
develop atrophy and metaplasia whereas mice treated with
IL27 are protected from disease as a result of the effect of
this cytokine on CD4 T cells.

BACKGROUND & AIMS: The association between chronic
inﬂammation and gastric carcinogenesis is well established, but
it is not clear how immune cells and cytokines regulate this
process. We investigated the role of interleukin 27 (IL27) in the
development of gastric atrophy, hyperplasia, and metaplasia
(preneoplastic lesions associated with inﬂammation-induced
gastric cancer) in mice with autoimmune gastritis.
METHODS: We performed studies with TxA23 mice (control
mice), which express a T-cell receptor against the Hþ/Kþ
adenosine triphosphatase a chain and develop autoimmune
gastritis, and TxA23xEbi3-/- mice, which develop gastritis but
do not express IL27. In some experiments, mice were given
high-dose tamoxifen to induce parietal cell atrophy and
spasmolytic polypeptide-expressing metaplasia (SPEM).

Recombinant IL27 was administered to mice with mini osmotic
pumps. Stomachs were collected and analyzed by histopathology and immunoﬂuorescence; we used ﬂow cytometry to
measure IL27 and identify immune cells that secrete IL27 in the
gastric mucosa. Single-cell RNA sequencing was performed on
immune cells that inﬁltrated stomach tissues.
RESULTS: We identiﬁed IL27-secreting macrophages and dendritic cell in the corpus of mice with chronic gastritis (TxA23 mice).
Mice deﬁcient in IL27 developed more severe gastritis, atrophy,
and SPEM than control mice. Administration of recombinant IL27
signiﬁcantly reduced the severity of inﬂammation, atrophy, and
SPEM in mice with gastritis. Single-cell RNA sequencing showed
that IL27 acted almost exclusively on stomach-inﬁltrating CD4þ T
cells to suppress expression of inﬂammatory genes.
CONCLUSIONS: In studies of mice with autoimmune gastritis,
we found that IL27 is an inhibitor of gastritis and SPEM, suppressing CD4þ T-cell–mediated inﬂammation in the gastric
mucosa. (Cell Mol Gastroenterol Hepatol 2020;10:561–579;
https://doi.org/10.1016/j.jcmgh.2020.04.014)
Keywords: Mouse Model; Immune Regulation; Lymphocyte;
Transcription.
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hronic inﬂammation is a driving factor in several
gastrointestinal disease processes, including gastric
cancer.1 Gastric cancer is the sixth most common and the
third most deadly cancer in the world, representing a signiﬁcant global health issue.2 This is in part because gastritis
is relatively common, primarily because of the high prevalence of Helicobacter pylori infections, but also other etiologies such as autoimmunity.3,4 Although adenocarcinoma is
associated most commonly with Helicobacter infection, a
recent study of patients with autoimmune gastritis–induced
metaplasia showed that these patients also have a signiﬁcantly higher rate of adenocarcinoma relative to the general
population.5 Furthermore, although overall gastric cancer
decreased in the United States between 1995 and 2003,
noncardia gastric adenocarcinoma is increasing. The increase of gastric cancer was attributed speciﬁcally in the
gastric corpus and disproportionately impacts young
women (age, <50 y).6 The decrease in H pylori infections in
the United States has led to speculation that this new gastric
cancer could be related to autoimmunity, which would
explain the predilection of this novel gastric cancer for
younger women. If this trend of increasing gastric adenocarcinoma continues, it potentially could result in an increase in overall gastric cancer cases.7
Host factors, such as cytokines produced by the inﬂammatory response, inﬂuence the development of gastric pathology and preneoplastic epithelial cell changes.8 This
indicates that the phenotype of an individual’s immune
response during autoimmunity likely inﬂuences their risk of
developing gastric cancer. Identifying cancer-promoting and
-inhibiting components of the immune response is expected to
provide signiﬁcant diagnostic and therapeutic advances for
patient care. In these studies, we used a mouse model of
autoimmune gastritis to identify an important role for a cytokine (interleukin [IL]27), that suppresses CD4 T-cell–mediated
inﬂammation in the gastric mucosa, thereby reducing the
degree of atrophy and metaplasia during gastritis.
The development of gastric cancer is associated with a
series of pathologic events in which chronic gastritis causes
the loss of parietal and mature chief cells (atrophy), the
development of mucous neck cell hyperplasia, spasmolytic
polypeptide-expressing metaplasia (SPEM), intestinal
metaplasia, dysplasia, and, eventually, adenocarcinoma.9,10
In recent years, there has been a focus on understanding
SPEM, which often arises concomitantly with parietal and
chief cell atrophy in a setting of chronic inﬂammation,
because it may be a critical precursor for the development
of intestinal metaplasia and adenocarcinoma.11,12 Although
the loss of parietal and chief cells is associated strongly with
the progression to metaplasia and carcinogenesis in this
paradigm, parietal cell deletion, in the absence of inﬂammation, is not sufﬁcient to induce metaplasia.13 In addition,
recent data indicate that the phenotype of the inﬂammatory
response is a critical determinant of SPEM development and
progression.14,15 Therefore, inﬂammation not only promotes
SPEM by damaging the epithelium and causing atrophy, it
also may inﬂuence the severity and phenotype of SPEM by
directly regulating metaplastic responses. We previously
determined that cytokines (interferon [IFN]g and IL17A)

secreted by immune cells can regulate the development of
atrophy and SPEM by acting directly on epithelial cells.16,17
Elucidating the mechanism(s) by which cytokines either
promote or prevent preneoplastic epithelial cell changes
will improve the understanding of the pathophysiology of
gastric carcinogenesis.
IL27 is a heterodimeric cytokine composed of 2 noncovalently associated proteins: p28 (encoded by the Il27
gene) and EBI3 (encoded by the Ebi3 gene). The
p28–Epstein-Barr Virus-Induced Gene (EBI3) heterodimeric
cytokine binds to the IL27 receptor, a heterodimer
composed of IL27 receptor A (IL27RA) and gp130. IL27
receptors can be expressed on multiple cell types, including
CD4 T cells. IL27 signals into T cells to promote the development of IFNg-producing Th1 cells, and prevents the
development of IL4-/IL13-producing T helper (Th)2 cells
and IL17A-producing Th17 cells.18,19 IL27 is pleiotropic and
has both proinﬂammatory and anti-inﬂammatory effects on
many immune cells aside from CD4 Th cells (depending on
the disease process and cell type acted upon).20–23 This
cytokine has not been well studied in the context of autoimmune gastritis and gastric carcinogenesis, but the fact
that IL27 regulates IFNg and IL17A suggests a potentially
critical role during gastritis because both of these cytokines
act directly on gastric epithelium to promote parietal cell
atrophy.16,17 Furthermore, it recently was determined that
IL27 is highly expressed during H pylori infection in human
patients.24 In addition, IL27 plays a critical role in regulating
the severity of disease in multiple mouse models of autoimmunity in various organ systems.25,26 This suggested that
IL27 may play a role in regulating autoimmune gastritis.
Studies of IL27 are complicated by the fact that the EBI3
subunit of the heterodimer also might pair with p35 protein
to form IL35, a poorly understood cytokine thought to be
produced by regulatory T cells to inhibit T-cell proliferation.27 Despite this possibility, recent studies have shown
that IL27 speciﬁcally, and not IL35, ameliorates disease
severity in several of these autoimmune conditions.28–30 In
the context of these previous studies, we sought to determine the role of IL27 in the progression of gastritis toward
gastric cancer, speciﬁcally in the development of key preneoplastic lesions, including atrophy and SPEM.
Here, we determined that IL27 was made in the mucosa
by macrophages and dendritic cells during chronic gastritis.

Abbreviations used in this paper: APC, antigen-presenting cell; cDNA,
complementary DNA; CD44v9, CD44 variant 9; EBI, Epstein-Barr VirusInduced Gene; EpCAM, epithelial cell adhesion molecule; GIF, gastric
intrinsic factor; GS-II, griffonia simplicifolia; HDT, high-dose tamoxifen;
IF, immunoﬂuorescent; IFN, interferon; IL, interleukin; MHC, major
histocompatibility complex; PBS, phosphate-buffered saline; PDX1,
pancreatic and duodenal homeobox 1; qRT-PCR, quantitative reversetranscription polymerase chain reaction; rIL27, recombinant interleukin 27; scRNA, single-cell RNA; SPEM, spasmolytic polypeptideexpressing metaplasia; Th, helper T cell; Treg, regulatory T cells.
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Figure 1. IL27 is secreted by macrophages/dendritic cells (DCs) in the gastric mucosa. (A) IL27 secretion measured by
enzyme-linked immunosorbent assay from gastric lymph node cells (grey) or gastric mucosal immune cells (black) of TxA23
mice at 2 months of age. Each dot represents the data from 1 mouse, and samples from the same mouse are connected by a
line. N ¼ 5 mice per group from 2 separate experiments. Signiﬁcance was determined using a Student t test. (B) Quantitative
real-time PCR gene expression analysis for the 2 subunits of IL27 (Il27 and Ebi3) in sorted and stimulated immune and
epithelial cells isolated from the gastric mucosa. Expression of target genes was relative to the Gapdh housekeeping gene.
Statistical signiﬁcance was determined using a Student t test. N ¼ 3–5 mice per group from 3 separate experiments.
(C) Representative ﬂow cytometry plots showing the gating strategy for identifying the presence of macrophages
(CD19-MHCIIþCD11bþCD11c-F4/80þ) and DCs (CD19-MHCIIþCD11b-CD11cþ) in the APC compartment of immune cells
ﬂushed from the gastric mucosa. ND, not determined.

To determine the role of IL27 during gastritis, Ebi3-/- mice,
which are unable to produce IL27 and IL35, were crossed
onto a model of chronic autoimmune gastritis, TxA23.
TxA23 mice express a transgenic T-cell receptor that is
speciﬁc for a peptide from the Hþ/Kþ adenosine triphosphatase a chain expressed by parietal cells. Autoreactive
CD4þ T cells induce chronic autoimmune gastritis spontaneously early in life. Atrophy and metaplasia develop in the
corpus of TxA23 mice, and similar to human beings with
autoimmune gastritis, the antrum is spared.31 TxA23 mice
mimic the disease progression observed in the corpus of
human patients, including gastritis that progresses to atrophic gastritis with mucinous hyperplasia/metaplasia,
development of SPEM, and, eventually, gastric

intraepithelial neoplasia.32 TxA23xEbi3-/- mice developed
much more rapid and severe inﬂammation and atrophy as
well as more extensive and proliferative SPEM throughout
the entirety of the gastric corpus compared with control
TxA23 mice. Studies using acute chemical parietal cell
ablation showed that Ebi3 was dispensable for SPEM
development in response to acute damage, indicating IL27
speciﬁcally regulates inﬂammation-induced atrophy and
metaplasia. Recombinant IL27 (rIL27) treatment prevented
mice from developing gastritis-induced atrophy and SPEM,
conﬁrming that IL27 protects the stomach during chronic
inﬂammation. Single-cell RNA (scRNA) sequencing analyses
determined that IL27 speciﬁcally suppressed tissueinﬁltrating effector CD4 T cells to reduce proinﬂammatory
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transcripts. Together, these ﬁndings show that IL27 production is critical for suppressing CD4 T cells during chronic
gastritis. In addition, they indicate that IL27 secretion in the
gastric mucosa plays an important role in preventing the
progression of gastritis to atrophy and metaplasia, critical
steps in gastric cancer development.

Results
IL27 Is Secreted by Macrophages and Dendritic
Cells in the Gastric Mucosa During Atrophic
Gastritis
Cytokines made in the gastric mucosa during inﬂammation likely contribute to the development of preneoplastic changes such as atrophy, hyperplasia, metaplasia,
and dysplasia that predispose to carcinogenesis. IL27 plays
a protective role in other inﬂammatory diseases,20,33 and
recently was detected at high levels in human patients with
chronic gastritis.24 We hypothesized that IL27 also may play
a protective role during gastritis. To determine whether
IL27 was secreted in the gastric mucosa of mice with
autoimmune gastritis, we measured IL27 secretion by immune cells in either the draining gastric lymph node or
inﬁltrating the stomach in these mice. Interestingly, we
found that IL27 was secreted by mucosa-inﬁltrating immune cells but was not detectable in the supernatants of
lymph node cells (0.2 ± 0.3 vs 59.8 ± 17.5 pg/mL)
(Figure 1A), indicating that IL27 could be a critical component of the tissue-speciﬁc immune response. To determine
which cell types were producing IL27 in the gastric mucosa,
we sorted B cells (CD19þ), T cells (CD3þ), antigenpresenting cells (APCs) (CD19–major histocompatibility
complex [MHC] IIþ), and epithelial cells (epithelial cell
adhesion molecule [EpCAM] positive) from the stomachs of
mice with chronic gastritis. The expression of Il27 (encoding
p28) and Ebi3 (encoding EBI3) was measured by quantitative reverse-transcription polymerase chain reaction (qRTPCR) to determine which immune cell subset expressed the
messenger RNA transcripts for both components of the IL27
protein. These analyses showed that APCs had the highest
relative expression of both Il27 and Ebi3 (Figure 1B).
Finally, to determine which cell types were present in the
APC population, we used ﬂow cytometry and identiﬁed that
the IL27-secreting APC population contained CD11bþF4/
80þ macrophages and CD11cþ dendritic cells (Figure 1C).
These results indicate that IL27 is made by macrophages
and dendritic cells in the gastric mucosa during chronic
gastritis.
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Ebi3 Expression Is Protective During Chronic
Atrophic Gastritis
To determine the importance of IL27 in the progression of chronic gastritis, TxA23xEbi3-/- mice that cannot
express IL27 were generated and a comparison of gastric
pathology between TxA23 and TxA23xEbi3-/- mice was
performed. TxA23xEbi3-/- mice developed rapid and more
severe gastritis pathology compared with control mice at
2 months of age, at which time TxA23 mice show mild
disease pathology (Figure 2A). To compare disease between stomachs from the 2 groups of mice, pathology was
scored using a rating system of 0–4, with 0 representing
healthy mucosa and 4 representing severe disease pathology, as previously described.32,34,35 Stomachs from
TxA23xEbi3-/- mice had signiﬁcantly more severe disease
compared with TxA23 mice in all pathologic categories,
including inﬂammation (3.1 ± 0.1 vs 1.4 ± 0.2), parietal
cell atrophy (3.5 ± 0.2 vs 1.3 ± 0.2), mucinous hyperplasia/metaplasia (foamy change resembling Brunner’s
glands in the oxyntic mucosa) (2.8 ± 0.4 vs 0.7 ± 0.2), and
mucosal hyperplasia (an increase in the overall thickness
of the gastric corpus mucosa) (3.2 ± 0.1 vs 1.6 ± 0.2)
(Figure 2B). The TxA23 model has been shown to progress
to dysplasia/gastric intraepithelial neoplasia as mice
age.32 To determine whether the early development of
severe gastritis pathology had implications for the eventual progression to later stages, we analyzed the development of abnormal, dysplasia-like pathology in control
and Ebi3-/- mice at 1 year of age. Control mice at this time
have severe inﬂammation, atrophy, and hyperplasia/hypertrophy, accompanied by foci of abnormally structured
glands that lack the normal mucinous appearance. Ebi3-/mice, however, have a much higher incidence of invasive
glandular structures throughout the corpus that inﬁltrate
the submucosa and muscularis. In addition, epithelial cells
in Ebi3-/- mice lose their normal mucus-ﬁlled appearance
on H&E, shown nuclear crowding with a loss of basal
nuclear localization, and some developed polyp-like
appearance not normally seen in the corpus. When
scored according to the dysplasia criteria published by
Rogers et al.34 TxA23xEbi3-/- had signiﬁcantly higher
scores owing to severe loss of gland orientation, cellular
atypia, and visible mitotic ﬁgures (0.63 ± 0.5 vs 2.75 ±
0.5) (Figure 2C). The rapid development of severe disease
in TxA23xEbi3-/- mice showed that Ebi3 expression is
critical for slowing the progression of inﬂammationinduced atrophy, hyperplasia, metaplasia, and eventual
dysplasia/gastric intraepithelial neoplasia.

Figure 2. (See previous page). Development of inﬂammation, atrophy, and hyperplasia occurs earlier in Ebi3-/- mice. (A)
Representative H&E-stained sections of murine gastric corpus from 2-month-old BALB/c, TxA23, and Ebi3 knockout. Yellow
box outlines high-magniﬁcation inset showing the degree of inﬂammation, parietal cell atrophy, mucinous hyperplasia/
metaplasia, and mucosal hyperplasia. (B) Pathologic scores for inﬂammation, parietal cell atrophy, mucinous hyperplasia/
metaplasia, and mucosal hyperplasia. Each dot represents the overall score given to 3 areas of gastric corpus from an individual 2-month-old mouse. N ¼ 7–11 mice per group from more than 3 experiments. (C) Representative H&E-stained
sections of murine gastric corpus from 12-month-old control TxA23 and TxA23xEbi3 knockout mice. Red arrows identify areas
in Ebi3-/- mice where glandular structures invade the submucosa and muscularis. A red box outlines abnormal branching
glands and cellular atypia within the gastric corpus. N ¼ 4 mice per group in at least 2 experiments.
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Ebi3 Protects From the Development of
Extensive Metaplasia (SPEM) and Increased
Epithelial Proliferation
SPEM, in the acute setting, is considered a tissue repair
response that resolves after restoration of normal tissue
architecture.36,37 However, in cases in which the cause of
long-lasting mucosal injury is not resolved, such as chronic
gastritis, SPEM is associated strongly with, and potentially is
the source of, cancer.38 SPEM is identiﬁed by co-staining for
neck cell markers (Mucin 6 [MUC6]/griffonia simplicifolia
[GS]-II lectin), chief cell markers (gastric intrinsic factor
[GIF] in mice), and a splice variant of CD44, CD44 variant 9
(CD44v9).39–41 Given that Ebi3-expressing TxA23 mice are
protected from the rapid development of atrophy, it seemed
likely that Ebi3 expression also affected the development of
SPEM. To test this, immunoﬂuorescent (IF) staining was
performed on the gastric corpus of TxA23 and TxA23xEbi3-/- mice with autoimmune gastritis to evaluate the
presence of parietal cells (vascular endothelial growth factor B, yellow), mucous neck cells (GS-II, green), and SPEM
cells (CD44v9, red). As expected at this time point, stomachs
of TxA23 mice had mild atrophy and patchy development of
SPEM in the few completely atrophic glands that were
observed (Figure 3A). However, in the stomachs of
TxA23xEbi3-/- mice, atrophy was severe and SPEM was
observed throughout the gastric corpus. SPEM was assessed
quantitatively by IF staining of multiple randomly selected
ﬁelds of view of the gastric corpus from each mouse (N ¼ 4
mice per group) to determine the percentage of glands that
contained CD44v9þ SPEM cells (Figure 3C). These analyses
showed that Ebi3-expressing mice had signiﬁcantly less
SPEM development compared with Ebi3-deﬁcient mice.
Because proliferating cells are at increased risk for mutational burden and eventual tumorigenesis, the role of Ebi3
expression in epithelial proliferation during gastritis also
was analyzed. The gastric corpus of wild-type and
TxA23xEbi3-/- mice was stained for GS-II (green) and the
proliferation marker Ki67 (pink) (Figure 3B). TxA23 mice
had a mixed phenotype with normal gland morphology,32
and with intermittent areas of SPEM and hyperplasia in
which the number of Ki67þ cells was minimally above
normal physiologic levels. However, in the stomachs of
TxA23xEbi3-/- mice, there was a signiﬁcant increase in the
proportion of proliferative gastric units in the gastric
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mucosa (Figure 3D) (88%–100% of glands having >20 vs
0%–21% of glands having >20). Another metric for the
advancement of metaplasia during carcinogenesis was the
expression of pancreatic and duodenal homeobox 1 (PDX1),
normally an antrum-speciﬁc nuclear protein, in the oxyntic
mucosal glands.42 SPEM regions were assayed in mice for
the expression of antralization marker PDX1 (pink) using
immunoﬂuorescence (Figure 3E). PDX1þ glands were not
detected in control TxA23 mice (left side of Figure 3E);
however, PDX1þ glands were observed throughout the
gastric corpus of TxA23xEbi3-/- mice. Therefore, these results show that Ebi3 expression is critical to slow the
development of proliferative SPEM during gastritis.

Ebi3 Is Not Required for SPEM in an Acute
Chemically Induced Setting
Because Ebi3 encodes a protein component of
IL27,18–22,25 and the receptor for this cytokine is expressed
on immune cells but not gastric epithelium, we hypothesized that Ebi3 expression was impacting disease by regulating the type and severity of inﬂammation. To test this
hypothesis, we used an acute, largely noninﬂammatory,
model of atrophy and SPEM development: high-dose
tamoxifen (HDT) administration. HDT treatment has been
used to rapidly (72 hours) and reversibly induce parietal
cell loss to study the mechanisms that underlie preneoplastic epithelial cell changes such as SPEM development in
the absence of chronic inﬂammation.43 BALB/c and BALB/
cxEbi3-/- mice were treated with 5 mg HDT per 20 g body
weight for 3 days according to published protocols.13,43
Importantly, there were no pathologic differences in the
gastric epithelium of BALB/c and BALB/cxEbi3-/- mice
treated with vehicle. As expected, HDT treatment caused
severe atrophy in more than 90% of the gastric corpus in
both strains of mice (Figure 4A). IF staining for GIF (yellow)
and GS-II (green) was used to assess the extent of SPEM
development in HDT-treated mice, showing a signiﬁcant
induction of GIFþGS-IIþ cells in both control and Ebi3-/tamoxifen-treated mice compared with vehicle-treated
controls (Figure 4B and C). It should be noted that
GIFþGS-IIþ normal progenitor cells were observed occasionally in the vehicle-treated gastric corpus, but were uncommon enough that the average was less than 1 across
50þ gastric units. SPEM development correlated directly

Figure 3. (See previous page). Ebi3-/- mice show more advanced metaplasia (SPEM) with antralization and increased
proliferation. (A) Representative immunoﬂuorescent staining of parietal cell atrophy and SPEM development in the gastric
corpus of 2-month-old BALB/c, TxA23, and TxA23xEbi3-/- mice. Blue, nuclear stain Hoechst; yellow, parietal cell–speciﬁc
vascular endothelial growth factor B (VEGF-B); green, neck cell–speciﬁc reagent GSII lectin; red, SPEM-speciﬁc surface
molecule CD44v9. (B) Representative immunoﬂuorescent staining of GSII (green), proliferation marker Ki67 (pink), and nuclear
stain 40 ,6-diamidino-2-phenylindole (DAPI) (blue) in the corpus of TxA23 and TxA23xEbi3-/- mice at 2 months of age. Yellow
box indicates high-magniﬁcation inset image. (C) Quantitation of the percentage of CD44v9þ glands from multiple ﬁelds of
view in 4 mice per group from healthy BALB/c mice, control TxA23 mice with chronic gastritis, and TxA23xEbi3-/- mice.
(D) Quantitation of Ki67 staining in the gastric corpus of 2-month-old BALB/c, TxA23, and TxA23xEbi3-/- mice as determined
by immunoﬂuorescent analysis shown in panel B. N ¼ 6 mice per group from 2 experiments with at least 25 gastric units in 3
separate ﬁelds of view analyzed per mouse. Statistical signiﬁcance was determined using 1-way analysis of variance.
(E) Representative immunoﬂuorescent staining of Pdx1þGSIIþ SPEM present in the gastric corpus of TxA23 and TxA23xEbi3-/- mice at 2 months of age. Left: GSII (green), Pdx1 (pink), DAPI (blue). Right: GSII (green), Pdx1 (pink), DAPI (blue). Yellow
box outlines high-magniﬁcation inset image.
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Figure 4. Ebi3 expression
does
not
inﬂuence
drug-induced metaplasia
development. (A) Representative images of H&Estained sections of the
gastric
corpus
from
vehicle-treated
BALB/c,
HDT-treated BALB/c, and
HDT-treated
BALB/
cxEbi3-/- mice between 6
and 12 weeks of age
showing the degree of parietal cell atrophy induced
by tamoxifen relative to
vehicle-treated
controls.
(B) Representative immunoﬂuorescent images of
gastric corpus from mice
treated as listed earlier.
Staining for Hoechst (blue),
GIF (yellow), and GSII
(green)
shows
SPEM
development. Images are
representative of more
than 90% of the gastric
corpus from 3 mice per
experimental group. (C)
Quantitation of the average
number of GIFþGSII- chief
cells (left) and GIFþGSIIþ
SPEM cells (right) in
vehicle-treated
BALB/c
(Veh) as well as tamoxifentreated BALB/c and BALB/
cxEbi3-/- mice. Calculated
from multiple ﬁelds of view
in 3 mice per group. Data
are means ± SD. Signiﬁcance was calculated using the Student t test.

with atrophy induction in the gastric corpus of both BALB/c
and BALB/cxEbi3-/- mice. These experiments determined
that Ebi3 expression does not alter the acute metaplastic
response to parietal cell loss, supporting the notion that it
regulates chronic inﬂammation.

rIL27 Administration Rescues Ebi3-/- Mice From
Accelerated Development of Atrophy and
Metaplasia During Gastritis
Because IL27 is made in the mucosa during gastritis and
Ebi3-/- mice have accelerated disease pathology, we hypothesized that IL27 was a protective cytokine during this
disease process. However, EBI3 protein is a component of

both IL27 and IL35, so it was crucial to establish that IL27
protected the gastric mucosa from the early development of
atrophy and SPEM. To address this, mini osmotic pumps
loaded with 4 mg/mL recombinant, covalently linked p28EBI3 (rIL27), were implanted subcutaneously into Ebi3-/mice 1 week after weaning. The rIL27 dose was based on
previous studies that successfully had prevented other inﬂammatory diseases using mini osmotic pumps loaded with
rIL27.20,33 Mice were killed 4 weeks after implantation and
the severity of gastritis pathology and metaplasia development was assessed using the pathologic and immunoﬂuorescent methods described previously. The stomachs of
rIL27-treated mice were much healthier than those from
untreated mice. There was a signiﬁcant reduction in the
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Figure 5. IL27 rescues Ebi3-/- mice from accelerated development of atrophy and metaplasia. (A) Representative images
of H&E-stained sections of the gastric corpus from sham pump–treated and rIL27 pump–treated mice at 2 months of age 1
month after pump implantation. Yellow box indicates high-magniﬁcation inset image. (B) Pathologic scores for inﬂammation,
parietal cell atrophy, mucinous hyperplasia/metaplasia, and mucosal hyperplasia. Each dot represents the overall score given
to 3 areas of gastric corpus from an individual mouse. (C) Representative immunoﬂuorescent staining indicating the extent of
SPEM in the gastric corpus of sham control and rIL27-treated mice. Hoechst (blue), GSII (green), GIF (yellow), and CD44v9
(red). Yellow box indicates high-magniﬁcation inset image. N ¼ 6–8 mice per group from 2 separate experiments. Statistical
signiﬁcance was determined using the Mann–Whitney U test.

extent of atrophy, mucinous hyperplasia/metaplasia, and
inﬂammatory inﬁltrate in H&E-stained sections of
gastric corpus from rIL27-treated TxA23xEbi3-/- mice
compared with controls (Figure 5A). rIL27-treated mice had
signiﬁcantly lower scores for inﬂammation (1.8 ± 0.3 vs

3.1 ± 0.2), atrophy (1.2 ± 0.4 vs 3.3 ± 0.4), mucinous hyperplasia/metaplasia (1.2 ± 0.5 vs 2.9 ± 0.4), and mucosal
hyperplasia (1.0 ± 0.4 vs 3.0 ± 0.3) (Figure 5B). Immunoﬂuorescent staining was used to assess the degree of SPEM
development. There was co-staining of GIF (yellow), GS-II
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Figure 6. IL27 supplementation reverses atrophy and metaplasia in TxA23 mice with established chronic gastritis. (A)
Representative images of H&E-stained sections of the gastric corpus from sham pump–treated and rIL27 pump–treated mice
at 4 months of age 1 month after pump implantation. Yellow box indicates high-magniﬁcation inset image. (B) Pathologic
scores for inﬂammation, parietal cell atrophy, mucinous hyperplasia/metaplasia, and mucosal hyperplasia. Each dot represents the overall score given to 3 areas of gastric corpus from an individual mouse. (C) Representative immunoﬂuorescent
staining indicating the extent of SPEM in the gastric corpus of sham control and rIL27-treated mice. Hoechst (blue), GSII
(green), GIF (yellow), and CD44v9 (red). Yellow box indicates high-magniﬁcation inset image. N ¼ 6–8 mice per group from 2
separate experiments. Statistical signiﬁcance was determined using the Mann–Whitney U test.

(green), and CD44v9 (red) diffusely throughout the corpus
mucosa of sham-treated mice whereas controls had little
to no SPEM development (Figure 5C), corresponding
with the pathology scores. These data show that rIL27 is

sufﬁcient to protect Ebi3-/- mice from accelerated disease
pathology, showing that the absence of IL27 is the
major cause of rapid disease development in TxA23xEbi3-/- mice.
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IL27 Supplementation in TxA23 Mice With
Ongoing Chronic Gastritis Allows for the
Regeneration of Normal Oxyntic Glands
Having shown that rIL27 suppressed atrophy and SPEM
development in TxA23xEbi3-/- mice, we next tested whether
therapeutic supplementation of rIL27 into TxA23 control
mice capable of producing IL27 could suppress disease
development. This was tested by implanting mini osmotic
pumps to deliver rIL27 into control TxA23 mice at 3 months
of age and pathology was evaluated at 4 months of age.
Stomachs from rIL27-treated mice were much healthier
than controls, in that healthy parietal and chief cells were
present in the glands and there was less mucinous hyperplasia/metaplasia throughout the corpus (Figure 6A).
Figure 6B shows that although mice treated with rIL27 had
similar degrees of inﬂammation, IL27 treatment signiﬁcantly decreased the severity of atrophy (2.5 ± 0.5 vs 1.2 ±
0.8), mucinous hyperplasia/metaplasia (2.2 ± 0.9 vs 1.2 ±
0.8), and mucosal hyperplasia (2.8 ± 0.4 vs 1.5 ± 1.0).
Finally, immunoﬂuorescent analyses of SPEM in the gastric
corpus showed that rIL27-treated mice had a corresponding
decrease in SPEM incidence compared with the widespread
SPEM present in control mice (Figure 6C). These data
showed that increasing IL27 above physiologic levels is an
effective way to stop disease progression.

IL27 Acts on Effector CD4þ T Cells to Reduce
Proinﬂammatory Gene Expression
IL27 is a pleiotropic cytokine with documented proinﬂammatory and anti-inﬂammatory effects on several cell
types including but not limited to CD4 T cells, CD8 T cells,
regulatory T cells (Tregs), macrophages, and dendritic
cells.20–22 Therefore, it was critical to determine the cellular
target(s) and effect(s) of IL27-mediated suppression of
gastritis, but our characterization of the immune response
using traditional ﬂow cytometry and bead-based enzymelinked immunosorbent assay approaches showed that immune cells in control and IL27-deﬁcient mice with gastritis
were similar in cell number, proportion of immune cell types
(including Th1/Th2/Th17/Treg cells), and cytokine secretion
proﬁles (Figure 7A, B, and D). These data led us to use scRNA
sequencing to identify the cell type(s) and transcriptional
response(s) to IL27 mediating its protective effect. Threemonth-old TxA23 mice were treated with phosphatebuffered saline (PBS) (control) or rIL27-loaded mini osmotic
pumps, as in the previous experiments. Immune cells were
ﬂushed from the gastric mucosa and subjected to scRNA
sequencing and transcriptional proﬁles of individual cells
were analyzed using established bioinformatic pipelines
(Seurat 3.0). Although scRNA sequencing does not capture
every transcript from every cell, data sets with more than
1000 cells analyzed correlated strongly with traditional bulk
RNA sequencing and closely recapitulate bulk transcriptome
complexity.44,45 These analyses led to the identiﬁcation of
individual immune cell types and the transcription response
of each cell type to IL27 treatment. Unsupervised clustering
and visualization of approximately 32,000 immune cells
identiﬁed and separated the immune cells inﬁltrating the
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gastric mucosa, including B cells, CD4 T cells, CD4þ Tregs,
CD8 T cells, gd T cells, natural killer cells, macrophages, mast
cells, and Slfn4þ myeloid—derived suppressor cells, which
have been associated with Helicobacter-induced gastric
metaplasia46 (Figure 8A). First, we determined that IL27 receptor (Il27ra) transcripts were detected at the highest levels
in T-cell clusters. This observation was supported further by
traditional ﬂow cytometry staining for IL27RA protein in
which T cells had the highest ﬂuorescent intensity, B cells/
macrophages/dendritic cells had much lower expression, and
epithelial cells did not express any IL27RA protein (Figures 7C
and 8B). Next, we compared the gene expression proﬁles of all
cell types between control and IL27-treated mice. Except for
CD4þ T cells, all other subsets of immune cells were transcriptionally indistinguishable. The CD4 effector cells inﬁltrating the gastric mucosa of IL27-treated mice had
signiﬁcantly lower expression levels of several genes that are
critical for T-cell–mediated inﬂammation, including chemokines Ccl5, Ccl4, and Ccl3; granule proteins involved in cytotoxicity, Nkg7 and Prf1; receptors for the T-cell growth/
activation cytokine IL2 (Il2rb); and the inﬂammationassociated chemokine receptor (Cxcr6) (Figure 8C–E).47,48
These results identify effector CD4 T cells as the primary
targets of IL27, and show that IL27 signiﬁcantly reduces inﬂammatory gene expression in these cells.

Discussion
It recently was determined that a novel and potentially
autoimmune-mediated gastric corpus adenocarcinoma is
increasing in young women in the United States.6,7 Autoimmune gastritis traditionally has been associated with neuroendocrine tumors, but the mounting evidence that it also
predisposes patients to adenocarcinoma of the corpus is a call
for better understanding of how chronic autoimmune
inﬂammation induces precancerous changes and eventual
neoplastic transformation. Cytokines serve as critical regulators of immune and epithelial cell functions during chronic
inﬂammation, but the identiﬁcation and mechanistic understanding of speciﬁc cytokines in the regulation of gastritis and
gastric precancer still is nascent. A critical observation made
in this study and in previous published work is that removal
or supplementation of a single cytokine within a complex
milieu during autoimmune gastritis resulted in drastic effects
on gastritis progression toward carcinogenesis (ie, atrophy
and SPEM development). For instance, we previously showed
that IL17A neutralization prevents the direct induction of
parietal cell apoptosis and decreases gastric atrophy.16 In
addition, IFNg,17,49,50 IL4,51 IL13, and IL3352 all have been
identiﬁed as components of the milieu that signiﬁcantly
regulate preneoplastic epithelial cell changes in the stomach.
The fact that gastric preneoplasia is sensitive to changes in
expression of so many immune factors implies that the types
of immune cells and cytokines involved in chronic gastritis
likely are playing a critical role in determining the likelihood
of carcinogenesis. Therefore, the further identiﬁcation and
mechanistic elucidation of other cellular and soluble components of the gastric inﬂammatory response will advance the
understanding of gastric carcinogenesis signiﬁcantly.
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HDT experiments in this study showed no signiﬁcant differences in the degree of atrophy or metaplasia development
between BALB/c and BALB/cxEbi3-/- mice, indicating that
Ebi3 expression does not affect the epithelial-autonomous
mechanisms that cells use to become metaplastic during
acute parietal cell ablation,53 but rather is a signiﬁcant inﬂuence during chronic inﬂammation. The initial observation that
TxA23xEbi3-/- mice rapidly develop severe inﬂammation, parietal cell atrophy, neck cell hyperplasia, as well as diffuse
SPEM compared with controls indicates that one of the
secreted factors encoded by this gene (IL27 or IL35) is an
important suppressive component of the cytokine milieu. Mini
osmotic pump restoration of IL27 determined that IL27 protects the gastric mucosa during gastritis. IL27-producing
macrophages and dendritic cells inﬁltrating the gastric tissue were identiﬁed. It could be that some macrophages are
protective rather than pathogenic during autoimmune
gastritis as a result of their expression of IL27, which is an
interesting avenue for further research into this critical immune cell compartment. Aside from the macrophage phenotype, this observation lent further credence to the hypothesis
that IL27 regulates stomach-speciﬁc immunity to control the
development of precancerous changes. Interestingly, IL27
production was not found in the draining lymph node, suggesting that IL27 controls on-site immune effector functions
rather than immune cell differentiation or priming that occurs
in the lymph node. Based on these data, immune cells were
ﬂushed from the stomach of untreated and IL27-treated mice,
and scRNA sequencing analysis was performed on more than
30,000 cells to determine the stomach-speciﬁc targets and
effects of IL27 during inﬂammation.
The use of scRNA sequencing allowed for description of
the tissue-speciﬁc immune response during chronic gastritis
including identiﬁcation of inﬁltrating immune cell types,
determination of cell populations that express the IL27 receptor and thereby are capable of responding to IL27, and
also a comparison of the entire captured transcriptome of
each cell type between sham-treated and IL27-treated cohorts
to determine the unique biological response of each cell type
to IL27 during gastritis. Although the receptor for IL27 was
found on several T-cell subsets, such as regulatory CD4 T cells
and CD8 T cells, these cell types showed no signiﬁcant alterations in their transcriptomes between the untreated and
IL27-treated conditions. Effector CD4 T cells, however,
showed the largest and most diverse transcriptional alteration
after IL27 supplementation. IL27 suppressed effector CD4
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transcripts associated with inﬂammatory functions including
the high-afﬁnity IL2 receptor, cytotoxic granule proteins, and
several chemokines that are involved in T-cell activation and
effector function. The fact that IL27 speciﬁcally suppresses
proinﬂammatory CD4 T cells is critical because CD4 T cells
are the mediators of gastritis in both autoimmunity and Helicobacter infection in mouse models and in human patients.
The fact that systemic administration of IL27 suppressed
tissue damage to the extent that normal oxyntic glands were
restored suggests that immunotherapeutic manipulation of
the cytokine milieu and inﬁltrating CD4 T cells during gastritis
could yield signiﬁcant clinical beneﬁts. Although recombinant
cytokines are difﬁcult to use therapeutically for a number of
reasons, identiﬁcation of which effector CD4 gene(s) suppressed by IL27 signaling are critical drivers of disease progression is a promising avenue for future study, perhaps by
performing bulk RNA sequencing of sorted CD4 T cells from
mice treated with IL27, because these effector functions may
serve as useful biomarkers of individuals at risk for carcinogenesis. In addition, progress in this area could provide
cytokine mimetics or neutralizing antibodies capable of
treating metaplasia after it has developed. However, an
important limitation of this study was that it uses a mouse
model of autoimmune gastritis. Although autoimmune
gastritis is associated with an increased risk of gastric
adenocarcinoma similar to H pylori infection,5 further studies
of this cytokine in other model systems are needed to broaden
the conclusions of this article beyond the autoimmune setting.
These data show that IL27 suppresses the development
of gastric precancer (atrophy and SPEM) in a setting of
chronic autoimmune inﬂammation, and even allows for
tissue regeneration if administered after the lesions have
developed. However, it is unclear what role IL27 plays after
tumorigenesis takes place. After development of a solid tumor, production of IL27 may inhibit antitumor immunity.54
Indeed, although IL27 was detected at high levels in gastric
tissue from human patients with H pylori–induced gastritis,
IL27 was not detected in the tissue of gastric cancer patients.24 This temporal change in IL27 expression based on
disease stage (eg, gastritis vs gastric adenocarcinoma) suggests that these same immunoregulatory activities that
prevent carcinogenesis during inﬂammation are harmful
after tumorigenesis. In addition, the role of IL35 in this
disease process requires further exploration. These studies
undoubtedly show that IL27 is protective during autoimmune gastritis and, based on the complete rescue of the

Figure 7. (See previous page). Control and Ebi3-/- mice with autoimmune gastritis have similar immune cell numbers,
proportions, and cytokine secretion proﬁles. (A) Total immune cell numbers isolated from the gastric lymph node (left) and
the gastric mucosa (right). Each dot represents 1 mouse, with 15–20 mice per group. (B) Total numbers of immune cell subsets
in control and Ebi3-/- TxA23 mice, with 15–20 mice per group. (C) Representative ﬂow cytometry histograms of IL27RA staining
on different immune subsets (red) compared with IL27RA-deﬁcient controls (gray), with 4–6 mice per group. (D) Analysis of
cytokines secreted by stomach-inﬁltrating immune cells that have been restimulated in vitro with PMA/ionomycin for 72 hours.
Supernatants were analyzed using a Milliplex bead-based cytokine assay (EMDMillipore; Burlington, MA). There were 3 mice
per group. Signiﬁcance was calculated using the Student t test. Ctrl, control; G-CSF, Granulocyte colony stimulating factor; IP10, Interferon-induced protein 10; KC, Keratinocyte chemoattractant; LIF, Leukocyte inhibitory factor; LIX, LPS induced CXC
chemokine; M-CSF, macrophage colony stimulating factor; MCP-1, monocyte chemoattractant protein 1; MIG, monokine
induced by gamma interferon; MIP, macrophage inﬂammatory protein; PMA, Phorbol 12-myristate 13-acetate; RANTES,
Regulated upon Activation, Normal T Cell Expressed and Presumably Secreted; VEGF, vascular endothelial growth factor.
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accelerated phenotype we observed in Ebi3-/- mice by rIL27,
we hypothesize that the role of IL35 is likely to be minimal.
However, interpretation of these results still is somewhat
limited by the lack of a direct treatment of mice with rIL35,
and further studies of IL35 in this context are warranted to
determine if this poorly understood cytokine plays a role. A
greater understanding of how to manipulate the immune
system, both before and after solid tumor formation, could
provide critical clinical advances in the identiﬁcation of atrisk individuals, early diagnosis of cancers, and novel
immunotherapeutic techniques.

Materials and Methods
Mice
TxA23 mice express a transgenic T-cell receptor speciﬁc
for a peptide from Hþ/Kþ adenosine triphosphatase a
chain on a BALB/c background, and have been described
previously.31,32,55,56 TxA23 mice were bred onto a BALB/
cxEbi3-/- background using mice purchased from Jackson
Laboratories (Bar Harbor, ME). All mice were maintained in
our animal facility and cared for in accordance with institutional guidelines. Studies were performed on a mixed
group of male and female mice with co-housed littermate
controls. For pump implantation studies, 800 ng of carrierfree rIL27 (2799-ML-010/CF; R&D Systems, Minneapolis,
MN) in 200 uL of sterile PBS was loaded into mini osmotic
pumps (model 2004; Alzet, Cupertino, CA) based on published effective doses in mice.20,33 Pumps were implanted
subcutaneously into TxA23xEbi3-/- upon reaching a 20 g
minimum weight (at approximately 5 weeks of age) or into
control TxA23 mice at 3 months of age. Mice were killed 4
weeks after implantation. Pumps containing only sterile PBS
were used as sham controls.

Histopathology
Stomachs were removed from mice, rinsed in saline,
immersion-ﬁxed in 10% neutral-buffered formalin, parafﬁn
embedded, sectioned, and stained with H&E. For scoring,
investigators were blinded, and sections from individual
mice were assigned scores between 0 (absent) and 4 (severe) to indicate the severity of inﬂammation, oxyntic atrophy, mucinous hyperplasia/metaplasia, and mucosal
hyperplasia.32,34

Immunoﬂuorescence
Stomachs were prepared, stained, and imaged using
methods modiﬁed from Ramsey et al.57 The primary antibodies used for immunostaining were goat anti–vascular
endothelial growth factor B (1:100, sc-13083; Santa Cruz
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Biotechnology, Dallas, TX), anti-CD44v9 (1:10,000,
LKGM002; Cosmo Bio, Carlsbad, CA), and goat anti-GIF
(1:10,000; a gift from David Alpers, Washington University
in St. Louis). After washing, sections were incubated with
secondary antibodies and GS-II lectin (1:500, L21415;
ThermoFisher, Waltham, MA). Sections were washed,
stained with Hoechst (62249; ThermoFisher) 1:20,000 in
PBS, and mounted in ProLong Gold Antifade mountant
(P36934; ThermoFisher).

Flow Cytometry
Cell surface staining was performed according to standard procedures using antibodies against CD4 (562891; BD
Pharmingen, San Jose, CA), CD8 (563046; BD Horizon, San
Jose, CA), CD19 (551001; BD Pharmingen), CD11b (550993;
BD Pharmingen), CD11c (550261; BD Pharmingen), F4/80
(123147; BioLegend), and MHC II. All ﬂow cytometry was
performed on a BD LSRII (BD Biosciences, San Jose, CA) and
analyzed using FlowJo (BD Biosciences, Ashland, OR).

HDT Treatment
The use of HDT to induce parietal cell atrophy and SPEM
development has been described previously.13,36,43 Tamoxifen (5 mg/20 g body weight, T006000; Toronto Research
Chemicals, North York, ON) was injected intraperitoneally
once daily for 3 days. Tamoxifen was dissolved in a vehicle
of 10% ethanol and 90% sunﬂower oil (S5007; Millipore
Sigma, St. Louis, MO). Determination of metaplasia induction
was performed by looking at 3 sections of gastric corpus per
mouse, in at least 3 mice per group.

Cell Sorting and qRT-PCR
After isolation from the gastric mucosa, cells were
stained with anti-CD45 BV786, anti-CD90 BV711 (563772;
BD Horizon), anti–MHC II AF488 (562352; BD Pharmingen),
anti-CD19 APC (550992; BD Pharmingen), and anti-EpCAM
APC ef780 (47-5791-81; Invitrogen), and sorted using a BD
FACsAria (BD Biosciences, San Jose, CA) into the following
groups:
CD45-EpCAMþ,
CD45þCD19þMHC
IIþ,
CD45þCD19-MHC IIþ, and CD45þMHC II-CD90þ. After
sorting, cells were restimulated overnight with phorbol
myristate acetate (25 ng/mL) and ionomycin (0.5 ng/mL).
RNA was isolated the following morning using a RNeasy
Mini Kit (74104; Qiagen, Germantown, MD). Complementary
DNA (cDNA) was generated using a high-capacity reversetranscription kit (4368814; ThermoFisher). The Gapdh, Il27,
and Ebi3 message was measured using TaqMan primer
probes according to the manufacturer’s speciﬁcations
(Gapdh: Mm99999915_g1; Il27: Mm00461164_m1; and

Figure 8. (See previous page). IL27 acts on effector CD4 T cells to reduce inﬂammatory gene expression during
autoimmune gastritis. Immune cells were ﬂushed and sort-puriﬁed from the gastric mucosa of sham-treated and IL27-treated
mice and subjected to scRNA sequencing analysis. (A) Uniform Manifold Approximation and Projection clustering of
approximately 32,000 immune cells sequenced. Each dot is an individual cell. Cells are colored by cluster identity. (B) Il27ra
expression in sequenced immune cell clusters. (C) Dot plot of the relative expression of all detected transcripts calculated from
the per-cell average relative expression from effector CD4 T cells identiﬁed in the untreated and IL27-treated libraries. (D)
Corresponding violin plots showing expression level of selected inﬂammatory genes in that effector CD4 T-cell subset. (E)
Select genes signiﬁcantly down-regulated by IL27 treatment in CD4þ T cells. MDSC, Myeloid derived suppressor cells; NK,
natural killer; pDC, peripheral dendritic cells.
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Ebi3: Mm00469294_m1; ThermoFisher). Expression was
reported as target relative to Gapdh for each sample. For
scRNA sequencing analysis, CD45þ propidium iodide cells
were sorted from the gastric mucosa to separate live immune cells from dead and epithelial cells. These cell suspensions then were washed once and loaded onto the 10
Genomics Chromium Controller according to the manufacturer’s recommendations.

Chromium Single-Cell 5’ Library Construction
The Chromium Single-Cell Controller instrument (10
Genomics, Pleasanton, CA) was used in these studies according to recommended manufacturer protocols and has
been described previously.58 Brieﬂy, gastric corpus epithelial single-cell suspensions were loaded on a Chromium
Single-Cell Controller instrument to generate single-cell gel
beads in emulsion. scRNA sequencing libraries were prepared using the Chromium Single-Cell 5’ Library and Gel
Bead Kit (P/N 1000006; 10 Genomics). RT of gel beads in
emulsion was performed in a Veriti 96-Well Thermal cycler
(4375786; Applied Biosystems, Foster City, CA): 53 C for 45
minutes, 85 C for 5 minutes, held at 4 C, and stored at
-20 C. The gel beads in emulsion then were broken, and the
single-strand cDNA was cleaned up with DynaBeads MyOne
Silane Beads (P/N 37002D; ThermoFisher, Waltham, MA).
Barcoded, full-length cDNA was ampliﬁed using the Veriti
96-Well Thermal Cycler: 98 C for 45 seconds, cycled 13:
98 C for 20 seconds, 67 C for 30 seconds, and 72 C for 1
minute, then 72 C for 1 minute, held at 4 C. The ampliﬁed
cDNA product was cleaned up with the SPRIselect Reagent
Kit (0.6  SPRI, P/N B23318; Beckman Coulter). 5’ gene
expression libraries were constructed using the reagents in
the Chromium Single-Cell 3’/5’ Library Construction kit (P/
N 1000020). For 5’ gene expression library construction,
these steps were followed: (1) fragmentation, end repair and
A-tailing; (2) after fragmentation, end repair and A-tailing
cleanup with SPRIselect; (3) adaptor ligation; (4) after ligation clean-up with SPRIselect; and (5) sample index PCR
and clean-up. Final quality control and Illumina sequencing
of the prepared libraries was performed by the Washington
University in St. Louis Genome Technology Access Center.

scRNA Sequencing Data Processing and
Statistical Analysis
Raw data were processed through the CellRanger 3.0
pipeline (10 Genomics) and secondary clustering and
differential expression analysis were conducted in Seurat/
R.59 Before clustering, all libraries and subsets were processed to ensure quality. Genes relating to mitochondrial
proteins are markers for broken or low-quality cells.60
Consequently, low-quality cells expressing high levels of
mitochondrial markers above a majority threshold unique
to each library/subset were ﬁltered out before downstream
analysis. Each library then globally was scaled and
normalized by a scale factor of 1  104 and log transformation. In addition, unwanted sources of variation
attributed to biological noise and batch effect were

identiﬁed and regressed out to improve downstream analysis and dimensionality reduction.61
Components for clustering were generated by canonical
correlation analysis. High-signal canonical correlates
explaining the most variance in comparison identity classes
were aligned by dynamic time warping, and their dimensions
were used for subsequent shared nearest neighbor clustering
and visualization by uniform manifold approximation and
projection for dimension reduction.62,63 Globally distinguishing genes for each cluster and comparison identity
class were identiﬁed by calculating the normalized gene
expression for the average single cell. Signiﬁcant genes with
at least a 2-fold change and a corrected P value less than .01
were identiﬁed via the Wilcoxon rank-sum test with Bonferroni correction for multiple comparisons.

Other Statistical Analysis
Data are expressed as means of individual determinations
± standard error. Statistical analysis was performed by
either the Mann–Whitney U test or an unpaired Student t-test
using GraphPad Prism 8 (GraphPad, San Diego, CA).
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